引用次数
引用: 28,310
H-指数: 49
I10-指数 : 90
出版物: 231
Declaración SPIRIT 2013: definición de los elementos estándares del protocolo de un ensayo clínico*
David Moher , Karmela Krleža-Jerić , Peter C. Gøtzsche , Kay Dickersin
Revista Panamericana De Salud Publica-pan American Journal of Public Health 38 ( 6) 506 -514
79
2015
Spirit 2013 statement: Defining standard protocol items for clinical trials
Karmela Krleža-Jerić , Peter C. Gøtzsche , Kay Dickersin , Douglas G. Altman
Chinese Journal of Evidence-Based Medicine 13 ( 12) 1501 -1507
1,458
2013
Evaluation of Efficacy and Safety of Nab-Paclitaxel vs Paclitaxel in Platinum-Refractory Metastatic Urothelial Cancer-Reply.
Srikala S Sridhar , Keyue Ding , Wendy R Parulekar ,
JAMA Oncology 7 ( 4) 634 -635
2021
Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years.
Julie Lemieux , Michael D. Brundage , Wendy R. Parulekar , Paul E. Goss
Journal of Clinical Oncology 36 ( 6) 563 -571
11
2018
Serum PD-L1 and outcomes in CCTG MA.31 phase 3 trial of anti-HER2 therapy in first-line HER2+ metastatic breast cancer patients (trastuzumab arm only).
Kim Leitzel , Suhail M Ali , Lois E Shepherd , Wendy R Parulekar
Journal of Clinical Oncology 36 1031 -1031
3
2018
Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP).
Christopher Sweeney , Wanling Xie , Meredith M. Regan , Mari Nakabayashi
Journal of Clinical Oncology 34 ( 15_suppl) 5023 -5023
5
2016
Outcomes of invasive ductal (ID) or invasive lobular (IL) early stage breast cancer in women treated with anastrozole or exemestane in the Canadian cancer trials Group MA.27.
Kathrin Strasser-Weippl , Gautam Sudan , Ravi Ramjeesingh , Lois E. Shepherd
Journal of Clinical Oncology 34 ( 15_suppl) 521 -521
2
2016
A randomized phase II/III study comparing stereotactic body radiotherapy (SBRT) versus conventional palliative radiotherapy (CRT) for patients with spinal metastases (NCT02512965).
Arjun Sahgal , Sten Myrehaug , Kristopher Dennis , Mitchell Liu
Journal of Clinical Oncology 35
10
2017
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial.
Prashanth Moku , Lois Shepherd , Suhail M. Ali , Kim Leitzel
Cancer 126 ( 22) 4859 -4866
1
2020
DASL-HiCAP (ANZUP1801): The impact of darolutamide on standard therapy for localized very high-risk cancer of the prostate—A randomized phase III double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high-risk, clinically localized prostate cancer.
Tamim Niazi , Scott Williams , Ian D. Davis , Martin R. Stockler
Journal of Clinical Oncology 38
1
2020
Cctg BL12: Randomized phase II trial comparing nab-paclitaxel (Nab-P) to paclitaxel (P) in patients (pts) with advanced urothelial cancer progressing on or after a platinum containing regimen (NCT02033993).
Srikala S. Sridhar , Normand Blais , Ben Tran , M. Neil Reaume
Journal of Clinical Oncology 36 ( 15_suppl) 4505 -4505
5
2018
CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC).
Ryan JO Dowling , Wendy R. Parulekar , Karen A. Gelmon , Lois E. Shepherd
Journal of Clinical Oncology 36 557 -557
4
2018
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
Pamela J. Goodwin , Vuk Stambolic , Julie Lemieux , Bingshu E. Chen
Breast Cancer Research and Treatment 126 ( 1) 215 -220
153
2011
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial
Srikala S. Sridhar , Normand Blais , Ben Tran , M. Neil Reaume
JAMA Oncology 6 ( 11) 1751 -1758
5
2020
CCTG HN.10: A phase II single-arm trial of elective volume adjusted de-escalation radiotherapy (EVADER) in patients with low-risk HPV-related oropharyngeal squamous cell carcinoma (NCT03822897).
Scott Victor Bratman , Eric Berthelet , James B. Butler , John R de Almeida
Journal of Clinical Oncology 38
2020
Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective
Ralph M. Meyer , Heather A. Stanton , Wendy R. Parulekar , Fred Saad
Cuaj-canadian Urological Association Journal 5 ( 6) 379 -381
2011
Defining the optimal treatment strategy for localized prostate cancer patients: a survey of ongoing studies at the National Cancer Institute of Canada Clinical Trials Group
Wendy R. Parulekar , Michael McKenzie , Kim N Chi , Laurence Klotz
Current Oncology 15 ( 4) 179 -184
6
2008
Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.
Wendy R. Parulekar , Andrew G. Day , Jon A. Ottaway , Lois E. Shepherd
Journal of Clinical Oncology 23 ( 25) 6002 -6008
110
2005
Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical Trial.
Lillian L. Siu , John N. Waldron , Bingshu E. Chen , Eric Winquist
JAMA Oncology 3 ( 2) 220 -226
38
2017
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Shuzhen Liu , Bingshu Chen , Samantha Burugu , Samuel Leung
JAMA Oncology 3 ( 11)
15
2017